3: Lundbeck ready to make acquisitions

Update: 2019-02-28

Description

Danish pharmaceutical company Lundbeck [CPH: LUN] is poised for a run of M&A to replenish its drug pipeline. We caught up with our Nordics reporter, Karoliina Liimatainen, who spoke recently with the company's chief executive, Deborah Dunsire, and has more on the company's plans for growth.

Comments

In Channel

2: Dealcast: Activism trends in 2020

2020-03-0219:24

1: Tipping Point - Shareholder Activism: Shift to bigger, healthier targets

2020-02-1119:08

8: Tipping Point: Deal Terms

2020-10-1327:18

7: Dealcast: Covid-19 and healthcare M&A

2020-04-2918:26

6: Tipping Point: Learning Good Habits in Bad Times

2020-04-2426:35

5: Tipping Point: COVID-19’s impact on M&A

2020-03-2527:37

3: Dealcast: LatAm M&A Policy Wrap

2020-03-0925:42

13: Dealcast: Vertical farming grows up

2019-11-1309:50

12: Dealcast: Allergan reaction

2019-08-0913:06

11: Dealcast: KKR’s play for Axel Springer

2019-06-2010:01

10: Dealreporter Asia: AGL Energy's offer for Vocus, Healius' investing in Japan and Kuyushu Railway Co's AGM

2019-06-1415:40

9: Dealcast Asia: Melco buys Crown stake, Qunar's surprise ruling

2019-05-3118:14

8: Dealcast: Tech listings go awry

2019-05-2909:20

7: Dealcast Asia: SAMR leadership change, the latest on Lynas and upcoming deals

2019-05-2412:03

6: Dealcast: The case for European telecoms M&A

2019-05-1010:54

5: Deutsche Bank and Commerzbank consider merger

2019-04-1509:18

4: Shareholder activism and private equity

2019-04-0413:35

3: Lundbeck ready to make acquisitions

2019-02-2807:44

2: Apollo/RPC faces possible rival bid from Berry

2019-02-0707:50

1: A look back at UK M&A in 2018, and 2019 predictions

2019-01-2511:23

00:00

3: Lundbeck ready to make acquisitions

#box-pro-ellipsis-176390940311925{-webkit-line-clamp:2;}3: Lundbeck ready to make acquisitions

3: Lundbeck ready to make acquisitions

Dealcast: The M&A Podcast

3: Lundbeck ready to make acquisitions